Journal Articles

The effect of current economic cuts to wound dressings and its impact on patients with epidermolysis bullosa: a case study

Share this article

The effect of current economic cuts to wound dressings and its impact on patients with epidermolysis bullosa: a case study

Annette Downe
14 March 2017

Epidermolysis bullosa (EB) is a rare group of genetically inherited skin fragility disorders (Denyer and Pillay, 2012). There are four major types of EB: simplex, junctional EB, dystrophic EB and Kindler (Fine et al, 2014). At present there is no cure for EB and patients suffer from lifelong wounding. Much of the clinical care is focused around symptom management: wound care, pain control, preserving function and palliative care. With this article, the author, an EB Clinical Nurse Specialist (CNS) working in a Tertiary Care Centre, gives an overview of the key issues and treatment regimens, while explaining the need for specialist care to help reduce the complications of living with this complex condition.

Free for all healthcare professionals

Sign up to the Wounds Group journals





By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.